January 11, 2023

君圣泰HTD1801治疗非酒精性脂肪性肝炎（NASH）的临床IIb 期研究（CENTRICITY研究）完成首例患者给药

ROCKVILLE, MD and SHENZHEN, CHINA, Jan 11, 2023 – (亚太商讯 via SEAPRWire.com) – 君圣泰（HighTide Therapeutics Inc.）…

January 5, 2023

君圣泰完成1.07 亿美元C/C+轮融资，加速推进在研管线的全球开发、商业化和商务拓展

ROCKVILLE, MD and SHENZHEN, CHINA, Jan 5, 2023 – (亚太商讯 via SEAPRWire.com) – 君圣泰（HighTide Therapeutics Inc.）宣…

August 9, 2022

Virios Therapeutics: The ‘Virus Hypothesis’ That Stands to Change the Lives of 10M Americans

NEW YORK, NY, Aug 9, 2022 – (ACN Newswire via SEAPRWire.com) – PCG Digital — Life may change for the better for the 10 million…

April 27, 2022

Legend Capital’s Portfolio Company Xbiome Acquires Clinical-Stage Program Targeting Ulcerative Colitis

HONG KONG, Apr 27, 2022 – (ACN Newswire via SEAPRWire.com) – Legend Capital’s portfolio company Xbiome Inc., an industry-leading and AI-driven microbiome therapeutics company, recently…

March 5, 2022

Altamira Therapeutics 与 Nuance Pharma 优锐医药签署独家协议，在中国及部分亚洲市场共同开发和商业化Bentrio(TM) 鼻喷剂

Hamilton, Bermuda, Mar 4, 2022 – (亚太商讯 via SEAPRWire.com) – Altamira Therapeutics Ltd. (NASDAQ: CYTO) (简称“Al…

March 5, 2022

Altamira Therapeutics and Nuance Pharma Enter Into Exclusive Licensing and Distribution Agreement for Bentrio in China and Additional Asian Markets

Hamilton, Bermuda, Mar 4, 2022 – (ACN Newswire via SEAPRWire.com) – Altamira Therapeutics Ltd. (NASDAQ:CYTO), a company dedicated to addressing unmet medical needs through RNA…

March 2, 2022

Oculis 获Accure Therapeutics授权引进用于治疗青光眼的神经保护候选药物进一步强化集团的领先眼科产品线

Lausanne, Switzerland, and Barcelona, Spain, Mar 2, 2022 – (亚太商讯 via SEAPRWire.com) – 利用突破性技术和革命性疗法从而改善视力及眼睛…

March 2, 2022

Oculis Strengthens Leading Ophthalmology Pipeline by In-Licensing Neuroprotective Drug Candidate for Glaucoma from Accure Therapeutics

Lausanne, Switzerland, and Barcelona, Spain, Mar 2, 2022 – (ACN Newswire via SEAPRWire.com) – Oculis S.A., (Oculis) a global ophthalmology company developing life-changing treatments to…

February 16, 2022

Moderna Announces Plan to Expand Footprint in Asia with Four Additional Subsidiaries

Cambridge, MA, Feb 16, 2022 – (ACN Newswire via SEAPRWire.com) – Moderna, Inc., (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines,…

February 11, 2021

Apollomics, Inc. and Iterion Therapeutics Announce Exclusive Collaboration and License Agreement to Develop and Commercialize Tegavivint in Greater China

FOSTER CITY, Calif. and HANGZHOU, China and HOUSTON, Texas, Feb 11, 2021 – (ACN Newswire) – Apollomics, Inc., an innovative biopharmaceutical company committed to the…

November 13, 2020

Fujitsu: Establishment of Joint Venture Aimed at the Development of Therapeutics for the Treatment of Coronavirus Disease

TOKYO, Nov 13, 2020 – (JCN Newswire) – PeptiDream Inc., a public Kanagawa-based biopharmaceutical company (TSE:4587), Fujitsu Limited (TSE:6702), Mizuho Capital Co., Ltd. which is…